Jack Higgins
Fortuna: 545 750 $ al 31/05/2026
Fortuna: 545 750 $ al 31/05/2026
Jack Higgins currently works at Immunome, Inc., as Chief Scientific Officer from 2023.
Dr. Higgins also formerly worked at Molecular Templates, Inc., as Chief Development Sciences Officer, Molecular Templates, Inc., as Chief Development Sciences Officer from 2019 to 2021, and MorphImmune, Inc., as Chief Scientific Officer from 2022 to 2023.
Dr. Higgins received his undergraduate degree from Texas A&M University and graduate degree and doctorate degree from The University of Arkansas.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNOME, INC. 0,02 % | 02/04/2026 | 25.000 ( 0,02 % ) | 545 750 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOME, INC. | Director Técnico/Científico/I+D | 02/10/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Director Técnico/Científico/I+D | 01/10/2023 |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Director de Operaciones | 01/06/2019 |
| MOLECULAR TEMPLATES, INC. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.